Open Access Highly Accessed Research article

Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden

Bengt Zöller1*, Xinjun Li1, Jan Sundquist12 and Kristina Sundquist1

Author Affiliations

1 Center for Primary Health Care Research, Lund University/Region Skåne, Clinical Research Centre, Floor 11, Building 28, Entrance 72, Skåne University Hospital, 205 02, Malmö, Sweden

2 Stanford Prevention Research Centre, Stanford University School of Medicine, Medical School Office Building, 251 Campus Drive, Mail Code 5411, Stanford, California, 94305-5411, USA

For all author emails, please log on.

BMC Neurology 2012, 12:41  doi:10.1186/1471-2377-12-41

Published: 18 June 2012

Additional files

Additional file 1:

Table S1. ICD codes of IMD and related conditions. Table S2. SIR for subsequent hemorrhagic stroke of male patients with IMD. Table S3. SIR for subsequent hemorrhagic stroke of female patients with IMD. Table S4. SIR for subsequent hemorrhagic stroke of patients with IMD after one year of follow-up. Table S5. SIR for subsequent hemorrhagic stroke of male patients with IMD after one year of follow-up. Table S6. SIR for subsequent hemorrhagic stroke of female patients with IMD after one year of follow-up. Table S7. SIR for subsequent ischemic stroke of male patients with IMD. Table S8. SIR for subsequent ischemic stroke of female patients with IMD. Table 9. SIR for subsequent ischemic stroke of patients with IMD. Table S10. SIR for subsequent ischemic stroke of male patients with IMD after one year of follow-up. Table S11. SIR for subsequent ischemic stroke of female patients with IMD after one year of follow-up. Table S12. SIR for subsequent hemorrhagic stroke of patients with IMD after one year of follow-up. Table S13. SIR for subsequent ischemic stroke of patients with IMD after one year of follow-up.

Format: DOC Size: 1.5MB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data